Michael N. Rosenblut, MBA, LNHA, CASP

President & CEO
Parker Jewish Institute for Health Care and Rehabilitation-New Hyde Park

Michael N. Rosenblut is President and Chief Executive Officer of the Parker Jewish Institute for Health Care and Rehabilitation, in New Hyde Park, New York, one of the nation’s preeminent health care and rehabilitation centers for adults; Founder and Chairman of the Board of Managers of AgeWell New York, a Managed Long Term Care Plan / and Medicare Advantage Plan / Medicaid Advantage Plan and President and CEO of the Queens-Long Island Renal Institute, Inc. Mr. Rosenblut continues to lead the fight against COVID-19 at Parker. He is a driving force in Parker’s nonstop COVID-19 testing operation, and successfully rolled out a vaccination program in partnership with Walgreens. Under his leadership, the Parker community is regularly updated about the pandemic and its robust safety measures implemented throughout the facility. Mr. Rosenblut serves on the Boards of LeadingAge New York (Immediate Past Chairman), Association of Jewish Aging Services, Continuing Care Leadership Coalition (Past) and the League of Voluntary Hospitals and Homes of New York. Mr. Rosenblut was featured in Long Island Business News’ Power 30 Healthcare list, which featured healthcare experts who led the region amid the COVID-19 pandemic in 2020. He was honored at the Long Island Press Power List Awards Gala, during April, 2018, at The Mansion at Oyster Bay. Long Island Press and the Power List Committee selected Mr. Rosenblut as one of the area’s most powerful health care movers and shakers. Mr. Rosenblut was also honored during 2018, by the New York Board of Rabbis, and in 2019, he was honored by the Long Island Alzheimer’s Foundation. Further, Mr. Rosenblut is a Past Vice President of Congregation Emanu-El of Westchester and serves as a member of the Board of Directors, at the Westchester Medical Center.